BCC Research
BCC Research

Fresenius SE & Co. KGaA

Company Snapshot

Founded: 1912
Entity Type: Public
Employees: 176,486
Region: Europe
Revenue: $23,299.6 Millions
Revenue Year: 2024
Headquarter: Bad Homburg, Germany
Key Geographics: North America, Europe, Asia-Pacific, Latin America, Africa

Company Overview

Fresenius SE & Co. KGaA is a global healthcare group that provides critical products and services for treating and caring for critically and chronically ill patients. It offers a range of healthcare products, including Levothyroxine Sodium for Injection, a treatment for hypothyroidism, and Lodixanol Injection, USP, a contrast agent for diagnostic imaging. The company provides innovative solutions across various therapeutic areas, supporting patient care in chronic conditions and medical diagnostics. Fresenius operates in over 60 countries through its subsidiaries, and it also has an international distribution network and over 50 production sites.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Fresenius SE & Co. KGaA In Reports

Global Thyroid Gland Disorders: Diagnostics and Treatment Market

Our detailed report on the Thyroid Gland Disorder Market trends It includes global revenue ($ Million) for the base year of 2023 and estimated data for the forecast period 2024 through 2029.

Intravenous (IV) Therapy and Vein Access: Global Markets

BCC Research Report: Dive into intravenous therapy and vein access market report breaks down revenues, while sales figures are estimated for the five years from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a CAGR of 7.7%.

View All Reports

Fresenius SE & Co. KGaA In News

Shareholder structure - freseniusmedicalcare.com

freseniusmedicalcare.com - Jan 20, 2025

These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Reasonably Well - simplywall.st

simplywall.st - Jul 06, 2025

Fresenius posts profit beat in first quarter, confirms outlook - Reuters

Reuters - May 06, 2025

Fresenius SE & Co KGaA (FSNUF) Q1 2025 Earnings Call Highlights: Strong EPS Growth and ... - Yahoo Finance

Yahoo Finance - May 08, 2025

Read All News

Applications/End User Industries

  • Healthcare
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions